Hospital · Private company
Northside Hospital, Inc.
Track this companyFree. Adds Northside Hospital, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials158 recruiting or active
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Clinical trials15
- Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AMLPHASE1 · NOT_YET_RECRUITING · started Jan 31, 2027ClinicalTrials.gov NCT07511062 · fetched Nov 12, 2026
- Axatilimab + CAR-T for High-Risk LymphomaPHASE1 · NOT_YET_RECRUITING · started Dec 31, 2026ClinicalTrials.gov NCT07638982 · fetched Nov 12, 2026
- Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant CyclophosphamidePHASE2 · RECRUITING · started Jul 3, 2025ClinicalTrials.gov NCT06828796 · fetched Nov 12, 2026
- CAR T-cell Therapy in Patients With Renal DysfunctionPHASE2 · RECRUITING · started Nov 18, 2024ClinicalTrials.gov NCT05909059 · fetched Nov 12, 2026
- Adding Venetoclax to the High-dose Chemotherapy Regimen Prior to Mismatche Allogeneic Stem Cell TransplantPHASE2 · WITHDRAWN · started Aug 31, 2024ClinicalTrials.gov NCT06337331 · fetched Nov 12, 2026
- Belumosudil and Rituximab for Primary Treatment of Chronic Graft-Versus-Host-DiseasePHASE2 · SUSPENDED · started Jan 29, 2024ClinicalTrials.gov NCT06046248 · fetched Nov 12, 2026
- Intrathecal Chemoprophylaxis to Prevent Neurotoxicity Associated With Blinatumomab Therapy for Acute Lymphoblastic LeukemiaPHASE2 · RECRUITING · started Jun 30, 2023ClinicalTrials.gov NCT05519579 · fetched Nov 12, 2026
- Reduced Intensity Fludarabine and TBI Prior to Haplo-Identical TransplantationRECRUITING · started Aug 29, 2022ClinicalTrials.gov NCT05417971 · fetched Nov 12, 2026
- Use of Convalescent Plasma for COVID-19PHASE2 · TERMINATED · started Jul 14, 2020ClinicalTrials.gov NCT04408040 · fetched Nov 12, 2026
- GM-CSF With Post-Transplant CyclophosphamidePHASE2 · RECRUITING · started May 18, 2020ClinicalTrials.gov NCT04237623 · fetched Nov 12, 2026
- Ibrutinib and Rituxan for Chronic GVHDPHASE2 · TERMINATED · started Dec 16, 2019ClinicalTrials.gov NCT04235036 · fetched Nov 12, 2026
- Lymphodepletion and Anti-PD-1 Blockade to Reduce Relapse in AML Patient Not Eligible for TransplantPHASE2 · COMPLETED · started Sep 28, 2016ClinicalTrials.gov NCT02771197 · fetched Nov 12, 2026
- Haploidentical Bone Marrow Transplant With Post-Transplant Cyclophosphamide for Patients With Severe Aplastic AnemiaPHASE2 · RECRUITING · started Sep 9, 2016ClinicalTrials.gov NCT02828592 · fetched Nov 12, 2026
- Reduced Intensity Conditioning Transplant Using Haploidentical DonorsPHASE2 · COMPLETED · started Oct 26, 2015ClinicalTrials.gov NCT02581007 · fetched Nov 12, 2026
- High Dose Chemotherapy Using BeEAM for Autologous Transplant in Multiple MyelomaPHASE2 · COMPLETED · started Apr 27, 2015ClinicalTrials.gov NCT02416206 · fetched Nov 12, 2026